BRIEF2A: The Gold-Standard in Executive Function Assessment for Adults Enhances Mental Health Treatment Nationwide

November 12, 2024 – PAR, Inc., a leading publisher of psychological assessments, has released the latest update to the gold-standard in executive function assessment, the BRIEF2A.  The BRIEF2A (Behavior Rating Inventory of Executive Function, Second Edition—Adult Version) is now available to help enhance the way clinicians evaluate and treat executive function deficits in adults. 

“The new features of the BRIEF2A not only enhance our customers’ ability to effectively evaluate adult executive function, but it also meets the need of having more assessment tools for their diverse clientele,” said Kristin Greco, CEO of PAR. 

Why Executive Function and ADHD Matter Now More Than Ever 

In adults with ADHD, executive function difficulties—such as trouble with focus, organization, follow-through, and impulse control—can deeply impact both personal and professional life. The BRIEF2A addresses a critical need, offering clinicians a comprehensive and reliable way to measure executive function in adults, leading to more targeted and effective treatment. 

“Our team has long understood the need for an up-to-date tool for adult executive function,” says Kristin Greco, CEO of PAR. “The BRIEF2A provides clinicians with an enhanced level of accuracy, making it an essential instrument for those treating adults with ADHD and a range of other cognitive challenges.” 

A New Tool for Today’s Mental Health Landscape 

With the BRIEF2A, PAR has expanded upon the gold-standard in executive function assessment, empowering clinicians with a versatile, life-spanning tool that is highly effective when evaluating adult ADHD, neurodegenerative conditions, and other cognitive challenges. As the focus of mental health becomes more prominent, the BRIEF2A positions clinicians at the forefront of high-quality, evidence-based care. 

New Features Deliver Up to Date Accuracy and Inclusivity 

Designed using  an updated normative sample based on the 2021 US census data and developed with the three-factor model: Behavioral, Emotional, and Cognitive regulation, found in the BRIEF2 (Behavior Rating Inventory of Executive Function, Second Edition), the gold-standard measure of executive functions for children ages 5 to 18 years, the BRIEF2A empowers clinicians to identify executive dysfunction in each individual. This advancement allows for more precise treatment planning and, ultimately, better outcomes. 

The BRIEF2A offers multirater capabilities, enabling feedback from caregivers, spouses, partners, or adult children to be directly compared to a client’s own assessment. A new progress monitoring report allows clinicians to track changes over time, ensuring treatment plans can evolve as patients improve or adapt to new challenges. With an age range that now extends to 99 years old and an updated Spanish-language translation, the BRIEF2A is designed to serve the needs of a diverse and aging population. 

Bridging the Gap from Adolescence to Adulthood in Mental Health 

The BRIEF2A marks a significant step forward in continuity of care for young adults transitioning from school-based programs. For students with Individualized Education Plans (IEPs) and executive function challenges that continue into adulthood, this tool allows clinicians to integrate BRIEF assessments seamlessly into adulthood, delivering critical continuity of care. 

“Continuity and accuracy in assessment are especially important for young adults with ADHD or executive function disorders who are leaving structured school environments for the first time,” explains Robert M. Roth, PhD, author of the BRIEF2A. “This tool enables clinicians to support those young adults as they navigate new responsibilities, new environments, and adulthood itself.” 

About PAR 

PAR is a leading publisher of psychological assessments dedicated to advancing mental health and educational evaluation with innovative, evidence-based resources. Known for its commitment to high-quality products that improve lives, PAR supports clinicians, educators, and researchers worldwide. 

For additional information or to purchase the BRIEF2A, visit parinc.com/products/BRIEF2A.